Sulfasalazine is well characterized for selectively suppressing the proliferation of CD44v-expressing cancer stem-like cells and KRAS-mutant cancer cells and markedly inhibiting tumor growth in several pre-clinical cancer models [61]. This evidence concerns the gene KRAS and neoplasm.